AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

AbbVie Inc. (NYSE:ABBV) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, Berenberg raised its price target on AbbVie Inc. (NYSE:ABBV) to $275 from $270, while ...

AbbVie (ABBV) reached $216.75 at the closing of the latest trading day, reflecting a -2.32% change compared to its last close ...

AbbVie is back in focus after a fresh price target update, putting the spotlight on how investors are reassessing the story ...

This healthcare giant is a top pick for growth and dividend investors.

AbbVie’s solid stock performance is driven by rising investor optimism as the company has successfully navigated the loss of exclusivity (“LOE”) of its blockbuster drug, Humira, which once generated ...

On November 5, Piper San‍dler analyst David Amsellem raised the price target on AbbVie Inc. (NYSE:ABBV) from⁠ $284 to $289 while maintaining an Over‌weight rating on the stock foll‌owing its ...

Some valuation metrics suggest that AbbVie is a cheap stock. The company's growth prospects through 2030 look attractive. AbbVie is also an excellent dividend stock. 10 stocks we like better than ...

In the current session, the stock is trading at $233.57, after a 0.52% spike. Over the past month, AbbVie Inc. (NYSE:ABBV) stock increased by 0.94%, and in the past year, by 40.22%. With performance ...